Gene genesight test. Medical search. Frequent questions

Since these studies were conducted, Assurex Health has enhanced the GeneSight test to include two more genes, CYP3A4 and CYP2B6, making it the first and only psychiatric pharmacogenomic test to offer CYP3A4 analysis distinct and separate from CYP3A5. (genesight.com)
Our New York Nurse Practitioners utilize GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. (basswellnesscenter.com)
It is the only neuropsychiatric pharmacogenomic test backed by such extensive research. (basswellnesscenter.com)
GeneSight Psychotropic is a pharmacogenomic test that analyzes clinically important genetic variations in your DNA. (benesserefamilywellness.com)
GeneSight® pharmacogenomic test batteries (Assurex Health, Inc. (simpleandpractical.com)
GeneSight® Psychotropic is a pharmacogenomic test that uses a proprietary algorithm to analyze 12 different genes to weigh their combined influence on patient response to more than 55 psychotropic medications. (islandpsychiatry.com)
A PGx test, or pharmacogenomic test, analyzes how genes may affect medication outcomes and can inform clinicians about how a patient may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions. (mentalpodcastshow.com)

Most single gene tests have high variability and are less accurate in predicting patient responses to psychotropic medications. (genesight.com)
The purpose is to determine through genetic testing which psychotropic medications are most helpful (or not) with mental health problems. (mayoclinic.org)
The GeneSight report shows whether there are gene-drug interactions for 64 FDA-approved psychotropic medications. (mentalpodcastshow.com)

The proprietary technology of the GeneSight Psychotropic test is based on combinatorial pharmacogenomics (CPGx™), the study of how variations in multiple genes collaborate to influence an individual's response to medications, and evidence-based medicine and the known clinical pharmacology of various drugs. (genesight.com)
The GeneSight Psychotropic test helps inform clinicians' treatment selection for commonly prescribed medications including those for depression, post-traumatic stress disorder (PTSD), anxiety, bipolar disorder and schizophrenia. (genesight.com)
Using a patient's unique genetics, the GeneSight Psychotropic test creates a personalized report that places 38 U.S. Food and Drug Administration (FDA)-approved medications for depression and other mental health conditions into three color-coded categories for clinicians to review: "Use as Directed" in green, "Use with Caution" in yellow, or "Use with Increased Caution and with More Frequent Monitoring" in red. (genesight.com)
The CYP2B6 gene affects medications including bupropion (Wellbutrin®), the third most commonly prescribed antidepressant. (genesight.com)
GeneSight is a blood test to determine which neuropsychiatric medications are indicated for an individual based on genetic analysis. (skepdoc.info)
It analyzes 57 neuropsychiatric medications and 12 genes. (skepdoc.info)
It also found patients whose providers did not have access to GeneSight were two times more likely to be prescribed medications with substantial gene-drug interactions. (myriad.com)
The GeneSight test uses a unique combinatorial algorithm, which evaluates how variations in multiple genes may influence an individual's outcomes with certain medications. (basswellnesscenter.com)
The GeneSight test analyzes genetic variation found in 14 total genes that may impact a patient's outcomes with certain medications. (basswellnesscenter.com)
Pharmacodynamic (PD) genes provide information on how your DNA may impact your likelihood of response or risk for side effects with some medications. (basswellnesscenter.com)
Myriad created the first test to measure the molecular biology and aggressiveness of men's prostate cancer, devised a method to assess the inherited breast cancer risk of any woman not previously diagnosed with breast cancer, regardless of ancestry, important for addressing racial and ethnic disparities, commercialized a psychotropic test that covers 61 medications commonly prescribed for depression, anxiety, ADHD. (wikipedia.org)
The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain medications. (benesserefamilywellness.com)
Their Impact Study re genes and medications was free. (mayoclinic.org)
Has anyone had the blood test/saliva test to determine what medications would be of value for you? (mayoclinic.org)
The GeneSight Psychotropic Test analyzes how your genes affect your response to medications commonly prescribed to treat depression, anxiety, bipolar disorder, posttraumatic stress disorder (PTSD), obsessive compulsive disorder, schizophrenia and other behavioral health conditions. (projectcourageworks.com)
GeneSight Psychotropic enables your clinician to identify and avoid medications that are unlikely to work or may cause side effects. (projectcourageworks.com)
Her clinician helped her find a prescription regimen that worked for her, in part by using the GeneSight test, which analyzes how a patient's genes may affect their outcomes with certain psychiatric medications. (multimedia-newsroom.com)
Genesight testing is a test that allows the NP to see what medications metabolize with the patients gene types. (americanhealthspecialist.com)
Testing your specific response to medications to reduce the risk of side effects and increase efficacy of medications using genetic profile which is done with a simple, quick swab test producing a comprehensive individual report. (islandpsychiatry.com)
Patients age 65+ whose clinician made treatment decisions congruent with the GeneSight Psychotropic test were on two fewer medications per year compared to those whose clinician made decisions incongruent with the test. (islandpsychiatry.com)
The GeneSight® test provides information on FDA-approved medications prescribed for specific conditions such as depression and anxiety, and analyzes how your patient's genes affect their response to these medications. (drjesalva.com)
The GeneSight Psychotropic test can help inform clinicians about genes that may impact how patients metabolize or respond to certain depression, anxiety, ADHD, and other psychiatric medications. (mentalpodcastshow.com)
The PRIME Care study's other co-primary endpoint showed that patients in the "treatment as usual" group were approximately two-fold more likely to be prescribed medications with predicted substantial gene-drug interactions compared to the GeneSight group in the first 30 days after randomization. (mentalpodcastshow.com)
A health care provider who can prescribe medications must order the GeneSight test kit. (mentalpodcastshow.com)
The comprehensive GeneSight Psychotropic report proves information about which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects based on the patient's genetic information. (mentalpodcastshow.com)
Not all patients who receive the GeneSight Psychotropic test will be prescribed medications with no or moderate gene-drug interactions. (mentalpodcastshow.com)
A number of panels of genetic tests for genes that have shown some association with the pharmacokinetics or pharmacodynamics of analgesic medications have been developed to aid in the management of pain. (radiologybillingcoding.com)
Their tests use proprietary algorithms to analyze results from multiple genetic tests to produce recommendations as to which medications are most likely to be the most effective and which to avoid to reduce the risk of side effects. (greygenetics.com)
The test offered by Gensight advertises that it analyzes genes related to over 50 medications. (greygenetics.com)
GeneSight testing is a breakthrough genetic testing technology that analyzes how your unique genetic makeup may affect your response to certain psychiatric medications. (solsticehealthcarellc.com)
By examining key genes involved in drug metabolism, the test provides valuable insights into which medications may be more effective and better tolerated for you as an individual. (solsticehealthcarellc.com)
With GeneSight, we can identify medications that are more likely to match your genetic profile, helping to optimize your treatment plan. (solsticehealthcarellc.com)

The GeneSight report also alerts healthcare providers to the implications of the patient's genetic information to a drug's dosage, and FDA-approved package insert information. (genesight.com)
The GeneSight approach compensates for these limitations by aggregating predictions by the drug metabolism and response genes to better predict patient's responses. (genesight.com)
In clinical studies published in peer-reviewed journals, using the GeneSight Psychotropic test has been shown to reduce symptoms of depression by 70% and double a patient's odds of response and remission compared to treatment as usual. (islandpsychiatry.com)
Gene-drug interactions are important because they can inform clinicians about a patient's ability to metabolize or respond to a certain medication. (mentalpodcastshow.com)
A DNA sample is collected through a simple cheek swab in a clinician's office or in the patient's home and sent to the GeneSight lab for analysis. (mentalpodcastshow.com)
One test, called GeneSight, uses a genetic analysis of DNA samples from a cheek swab to help doctors figure out which drugs are likely to combat a patient's depression. (ibcnj.com)

A test that analyzes how your genes may affect medication outcomes, especially useful for those who struggle finding the right medication. (opmhs.com)

The CPGx approach that generates the GeneSight report examines DNA variations of multiple genes since these variations can change the efficacy, metabolism, and adverse effects of many psychiatric drugs. (genesight.com)
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. (simpleandpractical.com)
The results, which will be unveiled this week at the American Psychiatric Association meeting, showed that patients fared better when physicians chose a medication with the help of the test, rather than relying solely on their judgment. (ibcnj.com)
How Does Genetic Testing for Psychiatric Medication Work? (pharmacogeneticstesting.com)
Psychiatric genetic testing is commercially available through a handful of companies. (greygenetics.com)
Is genetic testing to improve psychiatric treatment effective? (greygenetics.com)

This new publication shows that the combinatorial GeneSight test predicts which patients are likely to experience poorer antidepressant outcomes and use more health care services, whereas single gene diagnostics mostly did not," said lead author and Assurex Health Senior Vice President, C. Anthony Altar, Ph.D. "The robust evidence from these analyses reinforce the advantage of the combinatorial GeneSight test in helping clinicians guide antidepressant and anti-anxiety treatment decisions. (genesight.com)
In August 2016, Myriad announced it would acquire Assurex Health for up to $410 million, expanding the company's genetic testing for psychotropic medicine selection. (wikipedia.org)
GeneSight® is a test marketed in the US by a company called Assurex Health, Inc. Really it should be called a test battery or test panel since it consists of testing for multiple genes. (simpleandpractical.com)
The GeneSight test is provided by the Assurex Health clinical laboratory. (simpleandpractical.com)
Assurex Health, a subsidiary of Myriad Genetics, developed the GeneSight test. (ibcnj.com)

This analysis looked at the GeneSight test that included the liver metabolism genes CYP2D6, CYP2C19, CYP2C9, and CYP1A2, and the two drug response genes, SLC6A4 and HTR2A. (genesight.com)

They call their approach "combinatorial pharmacogenomic (CPGx™)" to indicate that they are making recommendations based on the combination of findings on the tests. (simpleandpractical.com)
Unlike other tests, GeneSight uses a proprietary combinatorial pharmacogenomic approach, which measures multiple genomic variants for each patient and weights them in combination to provide comprehensive, genetically-driven recommendations for each medication. (drjesalva.com)

Depression outcomes were recorded over 8 to 10 weeks for 119 fully blinded, treatment-resistant patients who were tested but neither they nor their clinicians received the GeneSight report. (genesight.com)
For clinicians like Dr. Fancher, the GeneSight test is an important objective test, similar to checking blood levels or taking blood pressure. (multimedia-newsroom.com)
Psychopharmacogenomic testing (AKA "Genomic Testing") is a new tool that has been available to clinicians during the last few years. (drjesalva.com)
One of the PRIME Care study's co-primary endpoints showed that, over 24 weeks, the group whose clinicians had access to the GeneSight test had a 28% greater likelihood of achieving remission from depression symptoms than the "treatment as usual" (TAU) group. (mentalpodcastshow.com)
Tens of thousands of clinicians have used the GeneSight test to help inform treatment plans for more than 2 million patients. (mentalpodcastshow.com)

Pharmacodynamic Genes COMT and ADRA2A. (simpleandpractical.com)

Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? (simpleandpractical.com)

Genetic tests can look for variations in those genes as well as in CYP1A2 and NAT2 which are involved in SSRI metabolism. (greygenetics.com)

Hi @summertime4 , you'll notice that I moved your message to this existing discussion called 'Why Genetic Testing for Mental Health Meds is Important. (mayoclinic.org)
A new national survey, the GeneSight Mental Health Monitor, found that when feeling overwhelmed, women say they "just need to take a break," with nearly a third believing they just need to try harder. (multimedia-newsroom.com)
MTHFR testing can help with treatment for mental health, neurological diseases and cardiovascular risk. (watsonwellness.org)
GeneSight testing empowers us to make informed decisions about your mental health treatment. (solsticehealthcarellc.com)
I wasn't even aware that they had genetic testing for mental health medication. (alike.health)

The GeneSight Psychotropic test accounts for this complexity by measuring and combining the DNA sequence variations within drug response and drug metabolism genes. (genesight.com)

Understanding the combinatorial approach of the GeneSight test starts with understanding our basic genetics: Each individual has a unique collection of genes responsible for their various genetic traits. (basswellnesscenter.com)
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. (wikipedia.org)
In the suit, medical associations, doctors, and patients sued Myriad Genetics to challenge seven United States patents on genes related to breast cancer and ovarian cancer. (wikipedia.org)
Natera: Panorama test - CPT codes: 88271, 88291 Invitae Genetics: Non-invasive Prenatal Screen test - CPT code: 81420 NxGenMDx: Informed Prenatal test - CPT code: 81420 Common ICD-10 codes: O09. (dobratechnologia.pl)

The MTHFR test alone is done at no cost. (simpleandpractical.com)
Another benefit of the test is testing for the MTHFR (methylenetetrahydrofolate reductase) gene. (drjesalva.com)
This is an important gene that codes for the enzyme MTHFR. (drjesalva.com)
MTHFR can be either inherited from our parents or acquired through lifestyle factors like diet and nutrition, which means that hereditary conditions and dietary choices can significantly impact how this gene behaves in the body. (thefashionablehousewife.com)
In this blog post, we'll discuss what exactly MTHFR is, get into some details regarding its function, and discuss the potential resulting implications to your physical well-being if you have any mutation or defect with your version of the gene. (thefashionablehousewife.com)
However, certain genetic variations in the MTHFR gene can cause a decrease in enzyme activity, which may lead to health problems such as elevated levels of homocysteine and an increased risk of cardiovascular disease. (thefashionablehousewife.com)
While MTHFR deficiency can be challenging to diagnose, individuals who are experiencing these symptoms should speak with their healthcare provider to determine if testing is needed. (thefashionablehousewife.com)

This has prompted interest in better targeting pain therapies through the use of pharmacogenetic testing of genes relevant to analgesic pharmacokinetics or pharmacodynamics. (radiologybillingcoding.com)

Pharmacokinetic (PK) genes are involved in how the body metabolizes, or breaks down, a particular medication through specific drug metabolizing enzymes. (basswellnesscenter.com)
A total of 16 genes are evaluated, both pharmacokinetic and pharmacodynamic. (simpleandpractical.com)

The estimates fluctuated inside ten from the reference case ICER (i.e., involving 56,259/QALY and 66,296/QALY vs. 60,564/QALY, reference case), and remained above a willingness-to-pay volume of 50,000 per QALY.TEST-SPECIFIC COST-EFFECTIVENESSAs previously talked about, multi-gene pharmacogenomic-guided interventions represent a heterogeneous class of tests, FP Purity & Documentation distinctive in their effectiveness and charges. (pkcinhibitor.com)
One example is, the ICER from the reference case for multi-gene pharmacogenomic-guided treatment versus therapy as usual more than three years was about 244 per QALY (compared using the reference case ICER of about 60,564 per. (pkcinhibitor.com)

It stands for methylenetetrahydrofolate reductase, a gene that helps our body break down and process vitamins. (thefashionablehousewife.com)

Its findings: "Pharmacogenetic testing did not significantly improve mean symptoms but did significantly improve response and remission rates [to a small degree, on the order of 26% vs. 19.9%] for difficult-to-treat depression patients over standard of care. (skepdoc.info)
A recent study by the U.S. Department of Veterans Affairs published in JAMA showed veterans are more likely to achieve depression remission when GeneSight test results are available to inform medication treatment. (myriad.com)
Hi, I'm new to this board and am wondering if any of you have had success with genetic testing for depression? (mayoclinic.org)
If a clinician is considering medication for someone struggling with depression, this test can help inform their treatment decisions and may help limit the trial-and-error-process. (mentalpodcastshow.com)
Depression and Personalized Medicine: Is Genetic Testing the Future? (greygenetics.com)
Since the early 2000s, efforts have been underway to incorporate genetic testing and pharmacogenetics into improving treatment of depression through personalized medicine. (greygenetics.com)
Major depression is influenced by a myriad of genes. (greygenetics.com)

Genesight , Genelex , and Genomind are some of the companies offering this type of testing. (greygenetics.com)

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. (simpleandpractical.com)

Not all patients who receive the GeneSight Psychotropic test will experience remission. (mentalpodcastshow.com)

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder. (simpleandpractical.com)

The GeneSight test takes into consideration all clinically relevant genes known to affect metabolism or response to a medication and assigns weights based on how big (or small) of a role it is expected to play in the medication's overall metabolism or mechanism of action. (basswellnesscenter.com)

Pharmacodynamic gene: OPRM1. (simpleandpractical.com)

The test predicts the effects of more than 50 anti-depressants and anti-psychotics. (ibcnj.com)

The test examines a dozen genes to determine how well the patient will metabolize certain drugs and how his or her brain will respond to them. (ibcnj.com)

That's why we are excited to offer GeneSight testing as part of our comprehensive approach to personalized care. (solsticehealthcarellc.com)

Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. (wikipedia.org)

GeneSight testing helps guide clinician prescribing by placing each medication into one of three color-coded categories: 'Use as Directed' in green, 'Moderate Gene-Drug Interaction' in yellow, or 'Significant Gene-Drug Interaction' in red. (islandpsychiatry.com)
After the GeneSight team receives the sample, the clinician will typically get test results in about two days. (mentalpodcastshow.com)

The test is expensive and not likely to be helpful for most patients. (skepdoc.info)
In a previous article , I argued that patients on Coumadin could be managed just as well without knowing genetic test results. (skepdoc.info)
Natasha Pyzocha, DO, writing in American Family Physician , comments that "consumer marketing of this test may lead patients to believe that it can predict medication response, when that may not be the case. (skepdoc.info)
Two years in, the company is reinventing itself to better serve a more patient-centric healthcare system - helping patients take control of their health, making genetic testing more accessible and affordable, and enabling healthcare providers to better detect, treat and prevent disease. (myriad.com)
We're putting patients and providers at the center of our mission to make genetic testing and data-driven medical information more widely available than ever before. (myriad.com)
We're integrating with Epic's electronic medical record platform and launching unified portals so patients and providers can have a single source for ordering, billing, cost-estimates and reports from multiple different tests. (myriad.com)
Myriad's GeneSight® psychotropic test helps reduce trial and error for patients struggling to find the medication that works for them. (myriad.com)
As of May 2017, over 39,000 healthcare providers have registered to use the test and over 500,000 patients have undergone testing. (simpleandpractical.com)
GeneSight has a great support program, and provides us with another tool that can help patients alleviate the stress of coming back more frequently and being disappointed that they're not getting better. (multimedia-newsroom.com)
This test is becoming more popular and it is very beneficial for patients who are having a hard time metabolizing medication. (americanhealthspecialist.com)
Other branches of medicine, such as oncology, have embraced gene-based testing to help determine which cancer patients need chemotherapy or surgery. (ibcnj.com)
Dr. Vahia has been using the gene test more with his older depressed patients but says clinical judgment remains paramount in prescribing. (ibcnj.com)
Among the 1,167 patients in the trial, half took the GeneSight test and half were prescribed drugs based purely on their doctors' clinical assessments. (ibcnj.com)
Why Patients Are Getting Hit With Surprise Bills After Genetic Testing. (dobratechnologia.pl)
Overall, the company gathers more information about cannabis and its genes and how patients can personalize these data. (nebula.org)
Over 95% of patients pay $330 or less for their GeneSight test. (mentalwellnessreleaf.com)

The GeneSight test can be performed on a single blood draw or on a buccal swab. (skepdoc.info)

Rarely is one single gene or set of genes a significant risk factor for more than a small percent of people. (greygenetics.com)

The GeneSight test analyzes clinically important genetic variations in your DNA. (basswellnesscenter.com)
If that happened (and Myriad protests that it won't happen), the physician report would no longer be the same Genesight report that was shown to be clinically effective in clinical trials. (discoveriesinhealthpolicy.com)

It is 100% accurate in detecting the genes, but according to the FDA only 13 antidepressants have enough pharmacogenetic evidence to warrant changes to therapy. (skepdoc.info)

MelixGX uses only modern and well-advanced technology for its tests and partners with third parties genetically and technologically advanced firms. (nebula.org)

The test is covered by Medicare, the U.S. Department of Veterans Affairs, and a growing number of commercial payers. (genesight.com)
Dr. Vahia told Ms. Dellovade about the genomics test, which retails for $1,500 and is covered by Medicare and some health plans. (ibcnj.com)

In our sensitivity analyses, which were specific to every single test, we showed considerable changes within the ICER and probability of costeffectiveness on the intervention compared with intervention with the GeneSight test, utilized within the reference case (see Appendix 13, Table A37). (pkcinhibitor.com)

Detoxification This test evaluates SNPs associated with increased risk of impaired detoxification capacity especially when exposed to environmental toxins. (watsonwellness.org)
Neurogenomics This test evaluates single nucleotide polymorphisms (SNPs) in genes that modulate methylation, glutathione conjugation, oxidative protection and the potential to evaluate vascular oxidation. (watsonwellness.org)

Also pioneering the field of DNA-specific medicine, Myriad received the first FDA approval for a lab-developed diagnostic test for use in predicting the responses to a DNA-repair drug. (wikipedia.org)
In July 2018, Myriad completed an acquisition of reproductive genetic testing firm Counsyl for $375 million, expanding the company's testing capabilities to carrier and prenatal screening. (wikipedia.org)
Among the prognostic tests developed and marketed by Myriad is "Prolaris", which uses gene expression profiling to provide a 10-year prostate cancer-specific risk of death. (wikipedia.org)
Myriad Genetics's patents on human genes became quite controversial. (wikipedia.org)
Following the discovery by Mary-Claire King that a gene on chromosome 17 is associated with an increased risk of breast cancer, Myriad attempted to patent this gene. (wikipedia.org)
Myriad also reported that FDA had directly asked it to change its reports for GeneSight, which Myriad believes it should not have to do. (discoveriesinhealthpolicy.com)
Myriad also dropped some specialized forms of the GeneSight test because of what it said was evidence that did not live up to its standards. (discoveriesinhealthpolicy.com)

It was a large (1,398 subjects) randomized controlled trial comparing subjects whose doctors had access to genetic test results to subjects who were treated as usual without such information. (skepdoc.info)
My PA doesn't recommend it - says it's too expensive and test results can limit what insurance companies will cover. (mayoclinic.org)
There is not enough medical evidence in published studies to show whether these genetic tests will improve overall health results. (radiologybillingcoding.com)
NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the first quarter ended. (dobratechnologia.pl)
Test results are ready in a few days. (mentalwellnessreleaf.com)

Genomics is coming to psychiatry, with some doctors using a gene test to figure out the most effective anti-depressant for a patient. (ibcnj.com)
Natera in the News Pros and Cons Pros Cons Nebula Genomics 7 Facts from our CENTOGENE Review Location: San Carlos, California Products: Women's health, oncology and organ health via cell-free DNA tests. (dobratechnologia.pl)

Commercially-available genetic tests for pain management consist of single-nucleotide variants (SNVs) or (less commonly) individual SNV testing. (radiologybillingcoding.com)

Now there is a test that offers to make such predictions: GeneSight psychotropic genetic testing. (skepdoc.info)

Our MyRisk™ Hereditary Cancer Test with RiskScore® for all ancestries offers a five-year and lifetime breast cancer risk assessment, which, for the first time, is available to women regardless of ancestry. (myriad.com)
Another prognostic test, marketed as "myRisk Hereditary Cancer", reviews genetic markers correlated with elevated risk of developing any of eight hereditary cancers. (wikipedia.org)

The GeneSight Psychotropic test has been evaluated in multiple published, peer-reviewed clinical studies. (basswellnesscenter.com)
GeneSight testing is backed by extensive scientific research and clinical studies. (solsticehealthcarellc.com)

J15 is part of the MOLDX policy system, but there is nothing about MOLDX or molecular testing in the SOW for J15. (discoveriesinhealthpolicy.com)
MelixGx is a DNA cannabis testing agency specializing in cutting-edge molecular genetic sciences. (nebula.org)

Pharmacogenomic test7

Psychotropic medications3

Medications32

Patient's6

Analyzes how your genes1

Psychiatric6

Assurex Health5

CYP2D61

Combinatorial Pharmacogenomic2

Clinicians5

Pharmacodynamic genes1

Outcomes1

CYP1A21

Mental health5

Drug metabolism1

Genetics4

MTHFR7

Analgesic1

Pharmacokinetic2

Multi-gene2

Methylenetetrahydrofolate reductase1

Depression7

Genomind1

Antidepressant1

Remission1

Major depressi1

Metabolism1

OPRM11

Predicts1

Examines1

Approach1

Proprietary1

Clinician2

Patients16

Swab1

Single gene1

Clinically2

Pharmacogenetic1

Genetically1

Medicare2

Analyses1

Evaluates2

Myriad7

Results5

Genomics2

Commonly1

Predictions1

Hereditary2

Clinical studies2

Molecular2